We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SFBS
2776
ServisFirst Bancshares
SFBS
$4.84B
$419K ﹤0.01%
12,225
+2,121
+21% +$70.8K
BIG
2777
DELISTED
Big Lots, Inc.
BIG
$419K ﹤0.01%
14,645
+430
+3% +$14.4K
CTO
2778
CTO Realty Growth
CTO
$805M
$418K ﹤0.01%
+25,806
New +$422K
LXP icon
2779
LXP Industrial Trust
LXP
$3.58B
$418K ﹤0.01%
8,887
-2,136
-19% -$98.6K
AOM icon
2780
iShares Core Moderate Allocation ETF
AOM
$1.77B
$417K ﹤0.01%
10,684
-39
-0.4% -$1.49K
GLQ
2781
Clough Global Equity Fund
GLQ
$157M
$417K ﹤0.01%
32,615
-12,211
-27% -$158K
RJET
2782
Republic Airways Holdings
RJET
$946M
$416K ﹤0.01%
3,037
-136
-4% -$18.8K
ICHR icon
2783
Ichor Holdings
ICHR
$2.43B
$415K ﹤0.01%
17,546
-5,141
-23% -$120K
AIF
2784
DELISTED
Apollo Tactical Income Fund Inc.
AIF
$414K ﹤0.01%
28,069
+3,377
+14% +$49.9K
NUVA
2785
DELISTED
NuVasive, Inc.
NUVA
$414K ﹤0.01%
7,075
-1,841
-21% -$109K
ATRA icon
2786
Atara Biotherapeutics
ATRA
$77.6M
$411K ﹤0.01%
818
-218
-21% -$154K
BKH icon
2787
Black Hills Corp
BKH
$5.62B
$411K ﹤0.01%
5,253
-763
-13% -$57.5K
ABDC
2788
DELISTED
Alcentra Capital Corp
ABDC
$410K ﹤0.01%
48,985
+2,558
+6% +$21.1K
DIS icon
2789
CALL
Walt Disney
DIS
$178B
$408K ﹤0.01%
18,600
-24,800
-57% -$3.29M
GDDY icon
2790
GoDaddy
GDDY
$11.6B
$408K ﹤0.01%
5,815
-2,753
-32% -$208K
FRA icon
2791
BlackRock Floating Rate Income Strategies Fund
FRA
$388M
$406K ﹤0.01%
31,627
+1,786
+6% +$23K
INDB icon
2792
Independent Bank
INDB
$3.97B
$406K ﹤0.01%
5,334
-547
-9% -$42.6K
ARLP icon
2793
Alliance Resource Partners
ARLP
$3.19B
$405K ﹤0.01%
23,867
-22,250
-48% -$404K
UFS
2794
DELISTED
DOMTAR CORPORATION (New)
UFS
$404K ﹤0.01%
9,069
-2,180
-19% -$99.6K
PFBC icon
2795
Preferred Bank
PFBC
$1.25B
$403K ﹤0.01%
8,538
-360
-4% -$16.9K
ANIP icon
2796
ANI Pharmaceuticals
ANIP
$1.74B
$402K ﹤0.01%
4,887
-425
-8% -$30.2K
BFZ
2797
DELISTED
BlackRock CA Municipal Income Trust
BFZ
$402K ﹤0.01%
30,320
-18,952
-38% -$248K
CARO
2798
DELISTED
Carolina Financial Corp.
CARO
$402K ﹤0.01%
11,445
-660
-5% -$23.5K
FBNC icon
2799
First Bancorp
FBNC
$2.68B
$399K ﹤0.01%
10,955
-1,410
-11% -$51.6K
FCN icon
2800
FTI Consulting
FCN
$4.17B
$397K ﹤0.01%
4,739
+611
+15% +$50.2K

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.